Skip to main content
Equibles

Connor, Clark & Lunn Investment Management Ltd.

Position in RARE — Ultragenyx Pharmaceutical Inc.

CIK 1596800 VANCOUVER, A1
Back to RARE Full portfolio

Position in RARE

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$6,396,789
-$4,097,526 QoQ
Shares Held
191,578
-61.8% QoQ
Ownership
0.194%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#73
of 311 holders
Holding Since
Dec 2020
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RARE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Connor, Clark & Lunn Investment Management Ltd. holds $648,992,404 across 104 Biotechnology names. RARE ranks #26 (1.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 135,236 $67,175,777
2 IONS
Ionis Pharmaceuticals Inc
 684,236 $54,253,072
3 ARWR
Arrowhead Pharmaceuticals, Inc.
 625,569 $50,990,129
4 MIRM
Mirum Pharmaceuticals, Inc.
 420,063 $49,176,775
5 REGN
Regeneron Pharmaceuticals, Inc.
 42,465 $26,478,625
6 AXSM
Axsome Therapeutics, Inc.
 97,698 $23,913,539
7 INSM
INSMED Inc
 212,676 $22,675,515
8 VKTX
Viking Therapeutics, Inc.
 530,607 $20,698,979

All Filings in RARE

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,396,789 191,578
2026-03-31 $10,494,315 500,922
2025-12-31 $6,068,987 263,869
2025-09-30 $2,373,973 78,922
2025-06-30 $213,978 5,885
2025-03-31 $1,625,865 44,901
2024-12-31 $1,136,563 27,016
2024-09-30 $4,180,970 75,265
2024-06-30 $6,694,820 162,891
2024-03-31 $7,261,462 155,525
2023-12-31 $4,134,373 86,457
2023-09-30 $6,496,677 182,235
2023-06-30 $9,504,210 206,031
2023-03-31 $8,335,105 207,858
2022-12-31 $10,664,888 230,194
2022-09-30 $7,802,513 188,421
2022-06-30 $1,943,782 32,581
2021-06-30 $224,739 2,357
2021-03-31 $1,760,958 15,466
2020-12-31 $363,517 2,626